HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci (Q40339467)
Jump to navigation
Jump to search
scientific article published on 8 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci |
scientific article published on 8 February 2017 |
Statements
1 reference
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci (English)
1 reference
David C Montefiori
1 reference
Giuseppe Pantaleo
1 reference
Mario Roederer
1 reference
Raphael Gottardo
1 reference
Georgia D Tomaras
1 reference
Kathryn E Foulds
1 reference
Nicole L Yates
1 reference
Steven G Self
1 reference
Beatriz Perdiguero
1 reference
Juan García-Arriaza
1 reference
Ralf Wagner
1 reference
Karen V Kibler
1 reference
Jim Tartaglia
1 reference
Sanjay Phogat
1 reference
Michael S Seaman
1 reference
Brian Burke
1 reference
Anthony D Cristillo
1 reference
Bhavesh Borate
1 reference
Susan W Barnett
1 reference
Deborah E Weiss
1 reference
Carter Lee
1 reference
Bertram L Jacobs
1 reference
Song Ding
1 reference
1 reference
1 reference
Identifiers
1 reference